Dow Jones

40,825.45

1.53%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

CGEN

Compugen (CGEN)

Compugen Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Anterior 5 6 7 8 9 10 11 12 13 14 15 16 17 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
16/09/2008	06:16	Edgar (US Regulatory)	Compugen Ltd - Report of Foreign Issuer (6-K)	NASDAQ:CGEN	Compugen Ltd
16/09/2008	06:00	Business Wire	Compugen Discovers Peptide Drug Candidate for Treatment of Solid Tumor Cancers and Announces Positive In Vivo Results	NASDAQ:CGEN	Compugen Ltd
10/09/2008	09:55	Marketwired	Leviev Group, Evogene and Orfuel to Establish a Biodiesel Company in Namibia, Africa	NASDAQ:CGEN	Compugen Ltd
28/08/2008	07:00	Marketwired	Monsanto and Evogene Collaborate on Yield and Stress Research	NASDAQ:CGEN	Compugen Ltd
14/08/2008	08:21	Marketwired	Evogene Reports Second Quarter 2008 Financial Results	NASDAQ:CGEN	Compugen Ltd
31/07/2008	07:34	Edgar (US Regulatory)	Compugen Ltd - Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:CGEN	Compugen Ltd
29/07/2008	06:00	Business Wire	Compugen Reports Second Quarter 2008 Results	NASDAQ:CGEN	Compugen Ltd
22/07/2008	06:00	Business Wire	Compugen Ltd. to Review Second Quarter 2008 Results on Tuesday, July 29, 2008	NASDAQ:CGEN	Compugen Ltd
16/07/2008	06:00	Business Wire	Compugen Planning Proof of Concept Human Trial for Breast Cancer Drug Candidate in 2009	NASDAQ:CGEN	Compugen Ltd
09/07/2008	06:00	Business Wire	Compugen Announces Positive In-Vivo Results for Therapeutic Peptide Candidate for Immune Related Diseases	NASDAQ:CGEN	Compugen Ltd
26/06/2008	06:00	Business Wire	Compugen Announces Discovery of Biomarkers for Early Pre-Clinical Detection of Drug-Induced Kidney Toxicity	NASDAQ:CGEN	Compugen Ltd
11/06/2008	06:00	Business Wire	Compugen Announces Discovery of Novel Drug Targets for Cancer Antibody Therapeutics	NASDAQ:CGEN	Compugen Ltd
27/05/2008	05:00	Business Wire	Compugen Ltd. to Highlight Company's Therapeutic Discovery Platforms at BioMed Israel 2008	NASDAQ:CGEN	Compugen Ltd
22/05/2008	06:00	PR Newswire (US)	[video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press From the Following: CGEN, C	NASDAQ:CGEN	Compugen Ltd
21/05/2008	08:20	Marketwired	Evogene Reports First Quarter 2008 Financial Results	NASDAQ:CGEN	Compugen Ltd
20/05/2008	06:30	Business Wire	Compugen Presents Experimental Results for Three G-Protein Coupled Receptor (GPCR) Ligands	NASDAQ:CGEN	Compugen Ltd
14/05/2008	06:00	Business Wire	Compugen Reports First Quarter 2008 Results	NASDAQ:CGEN	Compugen Ltd
06/05/2008	06:00	Business Wire	Compugen First Quarter 2008 Conference Call to Be Held 10:00 AM EDT Wednesday, May 14, 2008	NASDAQ:CGEN	Compugen Ltd
30/04/2008	09:00	Marketwired	Thanks Evogene Announces $2,000,000 Private Investment by AquAgro Venture Fund	NASDAQ:CGEN	Compugen Ltd
29/04/2008	07:00	Business Wire	Compugen Announces Discovery of Blood Based Biomarker for Diagnosis of Lung Cancer	NASDAQ:CGEN	Compugen Ltd
03/04/2008	06:20	Edgar (US Regulatory)	Compugen Ltd - Annual and Transition Report (foreign private issuer) (20-F)	NASDAQ:CGEN	Compugen Ltd
01/04/2008	06:00	Business Wire	Compugen Discloses Novel Troponin Variant for Identification of Cardiac Muscle Injury, Receipt of Patent for the Molecule and Co	NASDAQ:CGEN	Compugen Ltd
18/03/2008	07:00	Business Wire	Compugen Announces New Drug Discovery Platform to Predict Peptides that Block Disease-Associated Conformations of Proteins	NASDAQ:CGEN	Compugen Ltd
13/03/2008	08:30	Marketwired	Evogene Reports Fourth Quarter and Annual 2007 Results	NASDAQ:CGEN	Compugen Ltd
19/02/2008	06:00	Business Wire	Compugen Ltd. Reports Fourth Quarter and Year-End 2007 Financial Results	NASDAQ:CGEN	Compugen Ltd
14/02/2008	06:24	Edgar (US Regulatory)	Compugen Ltd - Amended Statement of Ownership (SC 13G/A)	NASDAQ:CGEN	Compugen Ltd
13/02/2008	09:00	Marketwired	Viterra and Evogene to Develop Canola With Improved Yield and Stress Tolerance Traits	NASDAQ:CGEN	Compugen Ltd
12/02/2008	06:00	Business Wire	Compugen Announces In-Vivo Results for Two Novel Peptide Agonists of MAS GPCR for Potential Treatment of Cardiovascular Patholog	NASDAQ:CGEN	Compugen Ltd
12/02/2008	06:00	Business Wire	Compugen Ltd. to Review Fourth Quarter and Full Year 2007 Results on Tuesday, February 19, 2008	NASDAQ:CGEN	Compugen Ltd
29/01/2008	06:00	Business Wire	Compugen Announces In-Vivo Results for Two Peptide Anti-Inflammatory and Cardio-Protective Drug Candidates	NASDAQ:CGEN	Compugen Ltd